Similar articles for PMID: 19204022

Year	Number of Results
2002	1
2003	2
2004	7
2005	5
2006	7
2007	7
2008	4
2009	5
2010	5
2011	13
2012	6
2013	8
2014	5
2015	5
2016	6
2017	1
2018	5
2019	6
2020	2
2021	2
2023	1
2024	2

1

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Lopez OL, Becker JT, Wahed AS, Saxton J, Sweet RA, Wolk DA, Klunk W, Dekosky ST. Lopez OL, et al. J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):600-7. doi: 10.1136/jnnp.2008.158964. Epub 2009 Feb 9. J Neurol Neurosurg Psychiatry. 2009. PMID: 19204022 Free PMC article.

2

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.

Kennedy RE, Cutter GR, Fowler ME, Schneider LS. Kennedy RE, et al. JAMA Netw Open. 2018 Nov 2;1(7):e184080. doi: 10.1001/jamanetworkopen.2018.4080. JAMA Netw Open. 2018. PMID: 30646339 Free PMC article.

3

The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer's disease to nursing homes: cost-effectiveness analysis in France.

Touchon J, Lachaine J, Beauchemin C, Granghaud A, Rive B, Bineau S. Touchon J, et al. Eur J Health Econ. 2014 Nov;15(8):791-800. doi: 10.1007/s10198-013-0523-y. Epub 2013 Aug 9. Eur J Health Econ. 2014. PMID: 23928827 Free PMC article.

4

[Cholesterol inhibitor and memantine in symptomatic dementia therapy].

Rodda J, Carter J. Rodda J, et al. Praxis (Bern 1994). 2013 Feb 27;102(5):293-300; discussion 298-9. doi: 10.1024/1661-8157/a001209. Praxis (Bern 1994). 2013. PMID: 23446240 Review. German. No abstract available.

5

Longitudinal medication usage in Alzheimer disease patients.

Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Zhu CW, et al. Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):354-9. doi: 10.1097/WAD.0b013e3181e6a17a. Alzheimer Dis Assoc Disord. 2010. PMID: 20625271 Free PMC article.

6

Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.

Tariot PN. Tariot PN. J Clin Psychiatry. 2006;67 Suppl 3:15-22; quiz 23. J Clin Psychiatry. 2006. PMID: 16649847 Review.

7

Memantine for dementia.

McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J. McShane R, et al. Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD003154. doi: 10.1002/14651858.CD003154.pub6. Cochrane Database Syst Rev. 2019. PMID: 30891742 Free PMC article.

8

Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease.

Zhu CW, Livote EE, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Zhu CW, et al. Alzheimers Dement. 2013 Nov;9(6):733-40. doi: 10.1016/j.jalz.2012.09.015. Epub 2013 Jan 17. Alzheimers Dement. 2013. PMID: 23332671 Free PMC article.

9

Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia.

Parsons C, Briesacher BA, Givens JL, Chen Y, Tjia J. Parsons C, et al. J Am Geriatr Soc. 2011 Jul;59(7):1253-9. doi: 10.1111/j.1532-5415.2011.03478.x. Epub 2011 Jun 13. J Am Geriatr Soc. 2011. PMID: 21668913 Free PMC article.

10

Treatment of Alzheimer disease.

Winslow BT, Onysko MK, Stob CM, Hazlewood KA. Winslow BT, et al. Am Fam Physician. 2011 Jun 15;83(12):1403-12. Am Fam Physician. 2011. PMID: 21671540 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year